Table 2.

Baseline characteristics

Characteristic	All subjects (n = 323)	Hepatocellular (n = 229)	Cholestatic (n = 56)	Miscellaneous (n = 38)	p value
Male gender	223 (69 %)	172 (75.1 %)	29 (51.8 %)	22 (57.9 %)	0.001
Age	51.6	51.6	49.7	54.6	0.041
BMI	28.0 ± 6.1	28.7 ± 6.0	25.0 ± 5.1	28.6 ± 7.1	< 0.001
LV/IBW (cm3/kg)	24.27 ± 9.67	22.75 ± 7.08	30.43 ± 12.06	24.37 ± 14.72	< 0.001
MELD	14.4 ± 6.6	14.9 ± 6.5	12.9 ± 7.5	14.1 ± 6.2	0.14
Terminal outcome, n (%)	283 (88 %)	200 (87 %)	48 (86 %)	35 (92 %)	0.39
Transplanted, n (%)	222 (68.7 %)	152 (66.4 %)	39 (69.6 %)	31 (81.6 %)
Died, n (%)	61 (18.9 %)	48 (21.0 %)	9 (16.1 %)	4 (10.5 %)
Time to terminal outcome (days)	561.1 ± 600.6	543.1 ± 599.1	619.5 ± 641.0	583.5 ± 555.3	0.68

BMI body mass index, LV liver volume, IBW ideal body weight